Demo

1680 Articles Matching "deal"

Apple's New Revenue Streams Are Everything About Timing - & Risk

Dec 12, 2018 , Forbes
Apple needs additional revenue streams, and it needs them now. Ideal revenue streams live in the Apple ecosystem. Products and services qualify but Apple needs to reduce risk by creating new product categories and new products and services instead of fast-following others into existing...
Read more

MaxQ AI signs CDS software distribution agreement, CareCloud expands to urgent care system, and more digital health deals

Dec 12, 2018 , Mobile Health News
Also: Hospital Sisters Health System integrates its SeamlessMD system with Epic's; Halifax Health reports strong results after implementing Nuance Healthcare's...
Read more

T-Mobile provides 70K lines of wireless service to the VA to support telehealth efforts

Dec 11, 2018 jonah.comstock@mobihealthnews.com (Jonah Comstock), Mobile Health News
The deal is part of a five-year $993.5 million contract between the DoD, T-Mobile, AT&T, and...
Read more

No-deal Brexit disruption at UK ports could last up to six months: minister

Dec 08, 2018 , Reuters
A no-deal Brexit could cause up to six months of disruption at some ports, a British minister warned on Friday, vowing to prioritise pharmaceuticals as the UK develops contingency plans less than four months before it is due to leave the EU....
Read more

Iowa let major Medicaid provider keep $2.4M in overpayments

Dec 07, 2018 , Modern Healthcare Breaking News
After a major provider agreed to stay in Iowa's troubled Medicaid program, a top aide to Gov. Kim Reynolds quietly signed a deal letting its hospitals and clinics keep $2.4 million in mistaken overpayments, according to...
Read more
Banner Health Children

Spok Health, Standard Communications ink deal to expand in VA systems

Dec 07, 2018 laura.lovett@himssmedia.com (Laura Lovett), Mobile Health News
The new partners plan on implementing Spok Care Connect, a medical messaging system, in their efforts to modernize the VA's communication...
Read more

Judge Considers Delaying CVS-Aetna Merger, Citing Potential Anti-Competitive Harms

Dec 07, 2018 , Kaiser Health News
But antitrust experts say it's only possible for the Department of Justice to block the merger. DOJ approved the $70 billion deal in October. Meanwhile, CVS and Aetna are moving ahead with integration plans. Other industry news looks at CVS' new prescription drug-price plans and rising costs of Pitocin and...
Read more

Walgreens launches next-day prescription delivery with FedEx to compete with Amazon

Dec 07, 2018 , CNBC Health
Amazon bought online pharmacy PillPack in June, but the deal has not closed yet, giving Walgreens and its rivals the chance to head off a possible disruption in the pharmacy...
Read more

U.S. judge concerned over government nod for CVS-Aetna deal

Dec 05, 2018 , Reuters
A federal judge who has been asked to sign off on the U.S. government's decision to approve CVS Health Corp's acquisition of insurer Aetna Inc said Tuesday he was "less convinced" than the government that the companies had struck a deal that ensured the merger was legal under antitrust law....
Read more

CHI and Dignity name executive team for CommonSpirit Health

Dec 05, 2018 , Modern Healthcare Breaking News
The California Justice Department conditionally approved the merger Nov. 21, which means the deal has met all necessary state, federal and Catholic regulatory approvals and is on track to close by Dec....
Read more

GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics

Dec 04, 2018 , Forbes
The deal is a dramatic bet that the London-based drug giant can see opportunities connected to the genetics of cancer drugs better than the stock market. It fits into a framework outlined in July by Hal Barron, the widely respected pharma veteran who took over as GSK’s head of R&D last...
Read more
Demo

Dutch firm argenx, J&J affiliate to collaborate on cancer therapy

Dec 04, 2018 , Reuters
Netherlands-based biopharmaceutical company argenx SE said it signed a deal with Cilag GmbH International, an affiliate of Johnson & Johnson's Janssen Pharmaceutical Companies unit, to develop its Cusatuzumab drug in certain types of cancer....
Read more

Tesaro surges 60% after GlaxoSmithKline agrees to buy it for $5.1 billion

Dec 04, 2018 , CNBC Health
The deal represents a more than 60 percent premium to Tesaro's closing price on Friday of $46.38 per...
Read more

After Years Of Rising Deductibles For Workers, Some Employers Are Tapping The Brakes

Dec 04, 2018 , Kaiser Health News
Instead of continuing the trend of passing on the burden of higher costs to employees, some companies are looking to address the underlying reasons for the spending. Among other strategies, some organizations are bypassing insurers and negotiating deals with hospitals directly and a growing number are offering their own clinics. Meanwhile, experiments that work to improve a patient's social factors, such as housing, are finding big savings....
Read more

Tabula Rasa Healthcare acquires fellow medication safety platform DoseMe

Dec 04, 2018 laura.lovett@himssmedia.com (Laura Lovett), Mobile Health News
As part of the deal Tabula Rasa will acquire the DoseMeRx platform, which gives clinicians information about how a patient will metabolize and absorb certain...
Read more

ResMed acquires digital respiratory health company Propeller Health

Dec 04, 2018 laura.lovett@himssmedia.com (Laura Lovett), Mobile Health News
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March...
Read more

What a judge can — and can't — do in ruling on the Justice Department's deal with CVS and Aetna

Dec 04, 2018 , CNBC Health
Judge Richard Leon is considering halting CVS Health and Aetna's integration. The Justice Department's agreement with the companies needs his approval, but he can't block the deal...
Read more

Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: 'It's A Challenge We Have To Solve'

Nov 30, 2018 , Forbes
In May Novartis announced that it had acquired the gene therapy pioneer AveXis in a $8.7 billion deal, but according to the the Swiss drug giant CEO Vas Narasimhan, he wishes he could have bought the company much...
Read more

Former Insys executive pleads guilty to opioid bribe scheme

Nov 29, 2018 , Reuters
A former executive at Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a scheme to bribe doctors to prescribe the company's powerful opioid medication and entered into a deal to cooperate with prosecutors....
Read more

Healthy Ways to Deal With Conflict

Nov 29, 2018 , MedicineNet
Title: Healthy Ways to Deal With ConflictCategory: Health NewsCreated: 11/27/2018 12:00:00 AMLast Editorial Review: 11/27/2018 12:00:00...
Read more